Baader Helvea Swiss Equities Conference, 11 January 2023
1
Disclaimer
Investing in the shares of CPH Chemie + Papier Holding AG involves risks. Prospective investors are urged to consult their investment advisors and tax advisors prior to investing in CPH Chemie + Papier Holding AG shares. This document contains forward-looking statements which involve risks and uncertainties. These statements are made on the basis of current knowledge and assumptions. Various factors could cause actual future results, performance or events to differ materially from those described in these statements. No obligation is assumed to update any forward-looking statements. Potential risks and uncertainties include such factors as general economic conditions, foreign exchange fluctuations, competitive product and pricing pressures and regulatory developments. The information contained in this document has not been independently verified and no representation or warranty, express or implied, is made to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. The information in this presentation is subject to change without notice, it may be incomplete or condensed, and it may not contain all material information concerning the CPH Group. Neither CPH Chemie + Papier Holding AG nor its affiliates shall have any liability whatsoever for any loss whatsoever arising from any use of this document or its content, or otherwise arising in connection with this document. This document does not constitute, or form part of, an offer to sell or a solicitation of an offer to purchase any shares, and neither it nor any part of it shall form the basis of, or be relied upon in connection with, any contract or commitment whatsoever. This information does not constitute either an offer to buy shares of CPH Chemie + Papier Holding AG or a prospectus within the meaning of the applicable Swiss law.
Baader Helvea Swiss Equities Conference, 11 January 2023
2
Agenda
1 The CPH Group
2 Business divisions
3 Investment case
Outlook
Q&A
Appendix: H1 results
Baader Helvea Swiss Equities Conference, 11 January 2023
3
The CPH Group Market position
Chemistry
StrategyDifferentiation
Market
3
position
Number 3 worldwide in molecular sieves
for industrial applications
Production
sites
PaperPackaging
Cost leadership
Differentiation
CHF 78.2 Mio.
CHF 9.5 Mio.
287
1
3
Number 1 in Switzerland
Number 3 worldwide
in newsprint and magazine
in coated barrier films for
paper manufacture and
pharmaceutical applications
in waste paper recycling
Brands
Baader Helvea Swiss Equities Conference, 11 January 2023
4
The CPH Group Value drivers
Megatrends
Healthcare
Energy
Circular economy
Brands
Pharma
Industry
Publishing
Applications
Agents
Petrochemicals
Ethanol
Industry
Printers Publishing houses
Products
Packaging films Molecular sieves Gels
Molecular sieves Energy production
Newsprint Magazine papers
Baader Helvea Swiss Equities Conference, 11 January 2023
5
Attachments
Original Link
Original Document
Permalink
Disclaimer
CPH Chemie + Papier Holding AG published this content on 06 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 January 2023 22:49:00 UTC.
CPH Chemie Papier Holding AG is a Switzerland-based company that develops, produces and distributes chemicals, papers and packaging films. It divides its activities into three divisions: Chemistry, Paper and Packaging. The Chemistry division is divided into fine chemistry, silicate chemistry and others. Fine chemistry product group focuses on production of organic chemicals for the pharmaceuticals industry. The silicate chemistry product group acts as a supplier of molecular sieves (zeolites) and silica gels for industrial applications. The Paper division focuses on production of newsprint primarily using raw materials and is divided into newsprint and magazine paper product groups. The packaging division provides full range of packaging products from PVC (polyvinyl chloride) monofilms to laminated high-barrier films that are primarily used in the manufacture of blister packs for medicinal products. Its major shareholder is UBV Uetikon Betriebs- & Verwaltungs AG with a stake of 49.9%.
CPH CHEMIE + PAPIER HOLDING AG 
